Open AccessANCESTRY OF BREAST CANCER PATIENTS IN BRAZIL
Author(s) -
René Aloísio da Costa Vieira,
Débora Sant’Anna,
Ana Carolina Laus,
Carlos E. Bacchi,
René Julias Costa e Silva,
Idam de OliveiraJunior,
Rui Pereira,
Rui Manuel Reis
Publication year - 2021
Publication title -
mastology
Language(s) - English
Resource type - Conference proceedings
eISSN - 2594-5408
pISSN - 2594-5394
DOI - 10.29289/259453942021v31s2002
Subject(s) - breast cancer , ancestry informative marker , ethnic group , indel , genetic genealogy , medicine , demography , cancer , oncology , biology , genetics , allele frequency , genotype , gene , population , single nucleotide polymorphism , environmental health , sociology , anthropology
Objective: To evaluate the ancestry of breast cancer (BC) patients from different Brazilian geographical regions and to associate it with molecular subtype. Methods: Ethics approval 1136/2016. This was an observational, transversal, epidemiological study, evaluating patients with BC. Molecular characterization of BC was performed by immunohistochemistry. DNA was extracted to evaluate ancestry. For analysis of ancestry, the AIM-INDEL panel was used, with 46 primer pairs. The polymerase chain reaction (PCR) products were subjected to capillary electrophoresis, and the results were analyzed using GeneMapper 4.0 software. For inference of the ancestral profile, the data were evaluated with Structure v. 2.3.3 software. Each participant was classified into one of the following ancestries: European, African, Amerindian, and Asian. Ancestry was tested for correlations with the geographical region and the molecular subtype. The differences were compared using the chi-squared and Kruskal–Wallis tests. SPSS v.20.0 for Windows was used analysis. Results: A total of 1,330 patients were included, out of whom it was possible to evaluate ancestry in 1,127. There was a difference in race, molecular subtype, and ancestry between the geographical regions. In the South region, there were higher rates of selfreported white ethnicity, European ancestry, and HER-2-luminal tumors, which may influence age at diagnosis and yield a higher rate of early tumors. Conversely, in the North and Northeast regions, there was a higher rate of African ancestry, self-reported nonwhite ethnicity, HER-2+ tumors, and triple-negative tumors. Triple-negative and HER-2+ tumors were associated with a higher rate of advanced and metastatic disease at diagnosis, with triple-negative tumors being more frequent in young women. Conclusions: This is the largest assessment of genetic ancestry in the Brazilian BC patients. There were differences in ancestry and molecular subtype between the different regions. Knowledge of these characteristics may contribute to a better understanding of the molecular distribution of cancer in these regions.